42 related articles for article (PubMed ID: 36624154)
1. MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer.
Boschheidgen M; Schimmöller L; Kastl R; Drewes LR; Jannusch K; Radke KL; Kirchner J; Ullrich T; Niegisch G; Albers P; Antoch G; Radtke JP
Abdom Radiol (NY); 2024 Jan; 49(1):192-201. PubMed ID: 37906272
[TBL] [Abstract][Full Text] [Related]
2. Value of Different Magnetic Resonance Imaging-based Measurements of Anatomical Structures on Preoperative Prostate Imaging in Predicting Urinary Continence After Radical Prostatectomy in Men with Prostate Cancer: A Systematic Review and Meta-analysis.
van Dijk-de Haan MC; Boellaard TN; Tissier R; Heijmink SWTPJ; van Leeuwen PJ; van der Poel HG; Schoots IG
Eur Urol Focus; 2022 Sep; 8(5):1211-1225. PubMed ID: 35181284
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. A preoperative magnetic resonance imaging-based model to predict biochemical failure after radical prostatectomy.
Pan M; Li S; Liu F; Liang L; Shang J; Xia W; Cheng G; Hua L
Sci Rep; 2023 Jan; 13(1):452. PubMed ID: 36624154
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
6. Preoperative MRI-based estimation of risk for positive resection margin after radical prostatectomy in patients with prostate cancer: development and validation of a simple scoring system.
Park MY; Park KJ; Kim MH; Kim JK
Eur Radiol; 2021 Jul; 31(7):4898-4907. PubMed ID: 33386982
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design.
Reichard CA; Kukreja J; Gregg JR; Bathala TK; Achim MF; Wang X; Davis JW; Nguyen QN; Chapin BF
Eur Urol Focus; 2021 Jan; 7(1):71-77. PubMed ID: 31076357
[TBL] [Abstract][Full Text] [Related]
8. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
Rajwa P; Mori K; Huebner NA; Martin DT; Sprenkle PC; Weinreb JC; Ploussard G; Pradere B; Shariat SF; Leapman MS
J Urol; 2021 Sep; 206(3):507-516. PubMed ID: 33904755
[TBL] [Abstract][Full Text] [Related]
10. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
11. MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy.
Manceau C; Beauval JB; Lesourd M; Almeras C; Aziza R; Gautier JR; Loison G; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M; Ploussard G
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33256176
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion.
Shin N; Park SY
AJR Am J Roentgenol; 2020 Oct; 215(4):913-919. PubMed ID: 32755167
[No Abstract] [Full Text] [Related]
14. Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study.
Murray NP; Aedo S; Fuentealba C; Reyes E; Salazar A; Lopez MA; Minzer S; Orrego S; Guzman E
Urol J; 2020 May; 17(3):262-270. PubMed ID: 31912475
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
